Ferhina Ali Last Word

Related

• 

  Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

  Dante Joseph Pieramici, MD

  Updates from the Field

  2017

• 

  TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease

  Peter K. Kaiser, MD FASRS

  Updates from the Field

  2020

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018